p38 mitogen-activated protein kinase inhibition decreases TNFalpha secretion and protects against left ventricular remodeling in rats with myocardial ischemia.
about
p38 MAPK in cardioprotection - are we there yet?Protein Kinases as Drug Development Targets for Heart Disease TherapyCrosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectivesExercise training reduces insulin resistance in postmyocardial infarction rats.Role of Mitogen-Activated Protein Kinases in Myocardial Ischemia-Reperfusion Injury during Heart TransplantationInvolvement of extracellular signal regulated kinases in traumatic brain injury-induced depression in rodentsThe role of proteomics in clinical cardiovascular biomarker discovery.MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets.Therapeutic regulation of cardiac fibroblast function: targeting stress-activated protein kinase pathways.Role of p38 inhibition in cardiac ischemia/reperfusion injury.Therapeutic potential of p38 MAP kinase inhibition in the management of cardiovascular disease.Mitogen-activated protein kinases pathways mediate the sunitinib-induced hypertrophy in rat cardiomyocyte H9c2 cells.Inhibition of p38 pathway leads to OA-like changes in a rat animal model.Sdc1 overexpression inhibits the p38 MAPK pathway and lessens fibrotic ventricular remodeling in MI rats.Apremilast reversed carfilzomib-induced cardiotoxicity through inhibition of oxidative stress, NF-κB and MAPK signaling in rats.Thrombopoietin protects against doxorubicin-induced cardiomyopathy, improves cardiac function, and reversely alters specific signalling networks.Ginsenoside-Rg1 enhances angiogenesis and ameliorates ventricular remodeling in a rat model of myocardial infarction
P2860
Q27001653-CB20EC00-F533-4F5F-A01B-3C3FFC2C67FCQ33678033-83B7A350-DFF5-436C-A926-9D4A91928983Q34289211-B937DE8F-7277-4756-9D48-FD386EF70E0BQ35588595-49A56550-21B0-402A-8AC9-14997EC42D2FQ35864123-1132AA1B-C440-4387-8394-F2562858545CQ37019266-77DC9640-770F-4EFC-8535-3967C877DD7DQ37230702-9B3B208D-7058-4A16-8DCA-1E76C665B919Q37254485-0D278660-CC3E-4B51-8B83-8AB805E7CE3DQ37934996-4FB1D532-3DF1-4129-819F-B17988923FB0Q37972088-669DEA50-03C8-4E7D-9801-C8089D96B913Q38185979-78BCDD1B-31B0-4909-9BA0-AA655D544B5CQ38979036-C245B6F5-FDD5-4FD2-9F67-BF49578E053FQ42500459-9393BCD7-2951-4AC6-AB83-84D93C24B7C7Q44934694-FC55A7C9-4737-42D9-9666-0040300A8D96Q51360501-C00BC2C8-0C73-45AC-8C2B-798CEE4B4C35Q54612094-799FD2D2-8C18-450D-80F6-554D9C1E1B60Q56558872-32B4C5EB-F877-41B2-B108-DEDF03BB3738
P2860
p38 mitogen-activated protein kinase inhibition decreases TNFalpha secretion and protects against left ventricular remodeling in rats with myocardial ischemia.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
p38 mitogen-activated protein ...... rats with myocardial ischemia.
@ast
p38 mitogen-activated protein ...... rats with myocardial ischemia.
@en
p38 mitogen-activated protein ...... rats with myocardial ischemia.
@nl
type
label
p38 mitogen-activated protein ...... rats with myocardial ischemia.
@ast
p38 mitogen-activated protein ...... rats with myocardial ischemia.
@en
p38 mitogen-activated protein ...... rats with myocardial ischemia.
@nl
prefLabel
p38 mitogen-activated protein ...... rats with myocardial ischemia.
@ast
p38 mitogen-activated protein ...... rats with myocardial ischemia.
@en
p38 mitogen-activated protein ...... rats with myocardial ischemia.
@nl
P2093
P1433
P1476
p38 mitogen-activated protein ...... rats with myocardial ischemia.
@en
P2093
Haiqing Lin
Huiqiu Yin
Jidong Zhang
P2888
P356
10.1007/S10753-007-9050-2
P577
2007-10-18T00:00:00Z
P6179
1007024601